换一批
换一批Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
第一作者：
Hideo,Tanaka
第一单位：
Department of Hematology and Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. dtanaka@hiroshima-u.ac.jp
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);细胞凋亡(Apoptosis);碱基序列(Base Sequence);DNA引物(DNA Primers);酶联免疫吸附测定(Enzyme-Linked Immunosorbent Assay);女(雌)性(Female);人类(Humans);干扰素γ(Interferon-gamma);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);男(雄)性(Male);中年人(Middle Aged);中性白细胞(Neutrophils);聚合酶链反应(Polymerase Chain Reaction);RNA, 信使(RNA, Messenger);TNF相关凋亡诱导配体(TNF-Related Apoptosis-Inducing Ligand);增量调节(Up-Regulation)
DOI
10.1111/j.1600-0609.2007.00834.x
PMID
17432976
发布时间
2008-11-21
- 浏览13
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
